Stockreport

Magenta Therapeutics Presents Preclinical Data on Targeted Non-Genotoxic Conditioning Programs, Including First Conditioning Development Candidate

Magenta Therapeutics, Inc.  (MGTA) 
Last magenta therapeutics, inc. earnings: 11/13 08:00 am Check Earnings Report
PDF -- Data in non-human primates from C100 program show potent stem and immune cell depletion with anti-CD45 amanitin ADC that is well tolerated at efficaci [Read more]